Financials
- Market Capitalization 2.16 B
- Employee 291
- Founded 2004
- CEO N/A
- Website www.urogen.com
- Headquarter Israel
- FIGI N/A
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-18.43
ratio cours/chiffre d'affaires
10.57
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1918 | MESO Mesoblast Limited - American Depositary Shares | 17.02 USD | -1.56% | -3.62% | +15.94% | +29.92% | 2.21 B USD | ||
| 1937 | ZYME Zymeworks Inc. - Common Stock | 30.67 USD | -1.22% | +7.16% | +36.86% | +72.89% | 2.18 B USD | ||
| 1945 | AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.18 USD | -0.68% | -1.94% | +9.25% | +35.62% | 2.15 B USD | ||
| 1951 | ZBIO Zenas BioPharma, Inc. - Common Stock | 33.40 USD | +0.81% | +0.39% | +7.43% | +26.23% | 2.18 B USD |